Replies to post #5908 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[peewee]

JGBO DD update / Jiangbo Pharmaceuticals still got 4 own drugs in FINAL developments...not talking about what they acquired earlier with that university acquisition ontop (22 products) !!

11 products already selling and we know they sell good and with high margins.
Saying they are lined up to serve the whole chinese market isnt that wrong aswell..hm ? LOL !
We do have a real winner here imo and many do still not know that company , lets see what happens when we get uplisting news sooner or later !!! :-D


Product Name
Use
Stage

Ligustrazine Ferulic Acid Acetate (LFAA)
Reduces blood clotting and prevents platelets in the blood from clumping together
Undergoing Phase III (final) clinical studies

Felodipine Sustained Release Tablets
Treats high blood pressure and arteriosclerosis.
Pending final SFDA approval

Yuandu Hanbi Capsules
Relief arthritis pain – Traditional Chinese Medicine
Pending final SFDA approval

Bezoar Yijin Tablets
Cures inflammations such as pharyngitis
Pending final SFDA approval